Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 491 - Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups , , or
Patents for C07D 491 - Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups , , or (29,726)
09/2014
09/30/2014US8846734 Diazonamide analogs
09/30/2014US8846712 6-(4-hydroxy-phenyl)-3-styryl-1H-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors
09/30/2014US8846702 Pyranyl aryl methyl benzoquinazolinone M1 receptor positive allosteric modulators
09/30/2014US8846684 Arbovirus inhibitors and uses thereof
09/30/2014US8846664 Pyrazinopyrazines and derivatives as kinase inhibitors
09/30/2014US8846663 Modulators of 5-HT receptors and methods of use thereof
09/30/2014US8846656 Tetrahydropyrido-pyridine and tetrahydropyrido-pyrimidine compounds and use thereof as C5a receptor modulators
09/25/2014WO2014152029A2 Oxazolo[5,4-c]quinolin-2-one compounds as bromodomain inhibitors
09/25/2014WO2014151784A1 Compounds and compositions for the treatment of parasitic diseases
09/25/2014WO2014150512A1 Method and products for treating diabetes
09/25/2014WO2014148047A1 Amine compound having hetero-fused ring and organic electroluminescent element using amine compound
09/25/2014WO2014147586A1 1-(2-(ethylamino)pyrimidin-4-yl)pyrrolidin-2-ones as inhibitors of mutant idh
09/25/2014WO2014147182A2 Novel compounds
09/25/2014WO2014146752A1 Materials for electronic devices
09/25/2014US20140288110 Ppar modulators
09/25/2014US20140288100 Galactokinase inhibitors for the treatment and prevention of associated diseases and disorders
09/25/2014US20140288091 Mono-fluoro beta-secretase inhibitors
09/25/2014US20140288046 Novel [1,2,3]triazolo[4,5-d]pyrimidine derivatives
09/25/2014US20140286899 Inhibitors of hepatitis c virus
09/24/2014EP2780343A1 Thieno- and furo - pyrimidines and pyridines, useful as potassium channel inhibitors
09/24/2014EP2780342A1 Aminoquinazoline derivatives and their salts and methods of use
09/24/2014EP2780338A1 Uracil derivatives as axl and c-met kinase inhibitors
09/24/2014EP2780325A1 Spiro dihydroacridine derivatives and the use thereof as materials for organic electroluminescence devices
09/24/2014EP2780321A1 Mono-fluoro beta-secretase inhibitors
09/23/2014US8841455 Substituted N-(1H-indazol-4-yl)imidazo[1,2-a]pyridine-3-carboxamide compounds as cFMS inhibitors
09/23/2014US8841448 Fluoroergoline analogs
09/23/2014US8841331 Inhibitors of human immunodeficiency virus replication
09/23/2014US8841298 Substituted pyrano[2,3-B]pyrazines as herbicides
09/23/2014US8841296 Substituted 1, 4-dioxa-8-azaspiro[4,5]decanes useful as fungicides and a process for the preparation thereof
09/23/2014CA2659050C Camptothecin derivatives with antitumor activity
09/23/2014CA2658902C Camptothecin derivatives with antitumor activity
09/18/2014WO2014144561A2 Lysophosphatidic acid detection
09/18/2014WO2014144326A1 Transient protection of normal cells during chemotherapy
09/18/2014WO2014143583A1 Imidazo pyridine compounds
09/18/2014WO2014142012A1 Ophthalmic composition for soft contact lens
09/18/2014WO2014140077A1 Furopyridines as bromodomain inhibitors
09/18/2014WO2014139458A1 Fused ring compound containing pyrimidine or pyridine and use thereof as anti-tumour drug
09/18/2014US20140275545 8-carboxamido-2,6-methano-3-benzazocines
09/18/2014US20140275529 Subunit selective nmda receptor potentiators for the treatment of neurological conditions
09/18/2014US20140275156 Flavonoid compounds, and methods of use thereof
09/18/2014US20140275155 Substituted bicyclic 1-carboxylic-acid (benzyl-cyano-methyl)-amides inhibitors of cathepsin c
09/18/2014US20140275154 Novel Compounds for the Treatment of Hepatitis C
09/18/2014US20140275093 Substituted hydroxamic acids and uses thereof
09/18/2014US20140275077 Uracil derivatives as axl and c-met kinase inhibitors
09/18/2014US20140275048 Prodrugs of fumarates and their use in treating various diseases
09/18/2014US20140275042 Tricyclic and tetracyclic systems acting upon the vascular and central nervous systems
09/18/2014US20140275024 Dna-pk inhibitors
09/18/2014US20140275023 Substituted Tricyclic Pyrazolo-Pyrimidine Compounds
09/18/2014US20140275021 Compounds useful as inhibitors of atr kinase
09/18/2014US20140275019 Tetrahydropyridine derivatives as fabi inhibitors
09/18/2014US20140275009 Compounds useful as inhibitors of atr kinase
09/18/2014US20140275006 Azole derivative
09/18/2014US20140275005 Substituted phenyl cycloalkyl pyrrolidine (piperidine) spirolactams and amides, preparation and therapeutic use thereof
09/17/2014EP2776418A1 Inhibitors of phosphodiesterase type 10a
09/16/2014US8835682 Alkaloid aminoester derivatives and medicinal composition thereof
09/16/2014US8835452 Polymorphic forms α, β and γ of rifaximin
09/16/2014US8835444 Cyclohexyl amide derivatives as CRF receptor antagonists
09/16/2014US8835442 3-substituted 7-imino-2-thioxo-3, 7-dihydro-2H-thiazolo [4,5-di pyrimidin-6-yl—and process for preparation thereof
09/16/2014US8835440 Cyclic pyrimidin-4-carboxamides as CCR2 receptor antagonists for treatment of inflammation, asthma and COPD
09/16/2014US8835420 Azaindole derivatives
09/16/2014CA2674530C Spirochromanon derivatives
09/12/2014WO2014138484A1 Perfluorinated cyclopropyl fused 1,3-oxazin-2-amine compounds as beta-secretase inhibitors and methods of use
09/12/2014WO2014136099A1 Process for ixabepilone, and intermediates thereof
09/12/2014WO2014135495A1 Antiviral compounds
09/12/2014WO2014135491A1 Novel heterocyclic fluorescent dyes and method of production thereof
09/12/2014WO2014135043A1 Crystal form of ixabepilone and the preparation method and use thereof
09/11/2014US20140256952 Process for ixabepilone, and intermediates thereof
09/11/2014US20140256706 Bet bromodomain inhibitors and therapeutic methods using the same
09/11/2014US20140256702 Neprilysin inhibitors
09/10/2014EP2774926A1 Morphinan derivative
09/10/2014EP2774912A1 Cationic lipid
09/10/2014EP2773634A1 Rod -like hepatitis c virus inhibitors containing the fragement {2- [4- (bi phenyl - 4 - yl) - 1h - imidazo - 2 - yl]pyrrolidine - 1 - carbonlymethyl} amine
09/10/2014EP2773623A1 1-(arylmethyl)-5,6,7,8-tetrahydroquinazoline-2,4-diones and analogs and the use thereof
09/09/2014USRE45128 Cephalotaxane derivatives and their processes of preparation and purification
09/09/2014US8829023 Process for obtaining compounds derived from tetrahydro-β-carboline
09/09/2014US8829017 Methods of treating traveler's diarrhea and hepatic encephalopathy
09/09/2014US8828991 Azacyclyl-substituted arylthienopyrimidinones, process for their preparation and their use as medicaments
09/04/2014WO2014132273A1 Substituted sugar derived 1, 2, 3-triazole compounds and their dimers and a process for the preparation thereof
09/04/2014US20140249312 [1,3]dioxolo[4,5-g]quinoline-6(5h)thione and [1,3]dioxolo[4,5-g][1,2,4]triazolo[1,5-a]quinoline derivatives as inhibitors of the late sv40 factor (lsf) for use in treating cancer
09/04/2014US20140249306 Hiv replication inhibitor
09/04/2014US20140249175 Anhydrate of tiotropium bromide
09/04/2014US20140249143 Compounds And Methods For Enhancing Innate Immune Responses
09/04/2014US20140249135 Pim kinase inhibitors and methods of their use
09/03/2014EP2770997A1 Substituted 2-(4-heterocyclylbenzyl)isoindolin-1-one analogs as positive allosteric modulators of the muscarinic acetylcholine receptor m1
09/02/2014US8822689 Aryloazol-2-yl cyanoethylamino compounds, method of making and method of using thereof
09/02/2014US8822688 Imidazo[1,2-a]pyridine derivative
09/02/2014US8822482 Icotinib hydrochloride, synthesis, crystalline forms, pharmaceutical compositions, and uses thereof
09/02/2014US8822448 Pyrazoloquinoline compound
09/02/2014CA2590756C Stereoselective process and crystalline forms of a camptothecin
08/2014
08/28/2014WO2014130258A1 5h-chromeno[3,4-c]pyridines as inhibitors of adaptor associated kinase 1 (aak1)
08/28/2014WO2014128486A1 Pyrimidine compounds useful in the treatment of diseases mediated by ikke and/or tbk1 mechanisms
08/28/2014WO2014128093A1 Substituted-imidazo[1,2-b]pyridazines as mknk1 inhibitors
08/28/2014WO2014061036A3 Tetraoxa diphosphaspiro compounds
08/28/2014US20140243324 Use of hematopoietic growth factor mimetics
08/28/2014US20140243313 Tricyclic compounds useful as neurogenic and neuroprotective agents
08/28/2014US20140243302 Bridged bicyclic compounds for the treatment of bacterial infections
08/28/2014US20140243290 Aminopyrimidines as SYK Inhibitors
08/28/2014US20140243288 Fused ring-containing oxazolidinones antibiotics
08/28/2014US20140242665 Phenyl Xanthene Dyes
08/28/2014US20140242027 Substituted pyridine and pyrimidine derivatives and their use in treating viral infections
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 ... 298